Could a smartphone app help diagnose ADHD?

NCT ID NCT07220330

ENROLLING_BY_INVITATION Diagnosis Sponsor: Qbtech AB Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing a smartphone app called QbMobile that measures attention, impulsivity, activity, and movement patterns. Researchers want to see if it can provide objective data to help diagnose ADHD in people aged 6 to 60. The study includes 700 participants with and without ADHD, and compares the app's scores to standard diagnostic methods.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: QbMobile (smartphone app)
What this could lead to: If successful, this could provide a reliable, objective tool to help doctors diagnose ADHD more accurately, both in clinics and remotely.
What could go wrong: This is an early validation study, not a treatment trial. The app may not prove accurate enough for widespread clinical use, and results may not apply to all populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATTENTION-DEFICIT/HYPERACTIVITY DISORDER (ADHD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

attention deficit hyperactivity disorder, inattentive type attention deficit-hyperactivity disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ATTENTION-DEFICIT/HYPERACTIVITY DISORDER (ADHD) HEALTHY VOLUNTEER NO HISTORY OF ADHD

Contacts and locations

Locations

Bokhari Medical Consortium

Largo, Florida, 33770, United States
Nona Pediatric Center

Orlando, Florida, 32832, United States
Prodigy Psychiatric Group

San Jose, California, 95138, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.